Related Experiment Video

Updated: Feb 2, 2026

Modeling Chemotherapy Resistant Leukemia In Vitro
08:41

Modeling Chemotherapy Resistant Leukemia In Vitro

Published on: February 9, 2016

9.6K

PARP inhibitor re‑sensitizes Adriamycin resistant leukemia cells through DNA damage and apoptosis

Jie Wu1, Sheng Xiao1, Miaomiao Yuan1

  • 1Department of Hematology, The Third Xiangya Hospital of Central South University, Changsha, Hunan 410013, P.R. China.

Molecular Medicine Reports
|November 16, 2018
PubMed

Insights

Olaparib combined with Adriamycin (ADR) re-sensitizes leukemia cells to chemotherapy by increasing DNA damage and apoptosis. This combination therapy shows promise for treating drug-resistant leukemia.

Area of Science:

  • Oncology
  • Pharmacology
  • Molecular Biology

Background:

  • Adriamycin (ADR) resistance is a significant challenge in leukemia treatment.
  • Olaparib, a PARP inhibitor, has shown antitumor activity and the potential to overcome drug resistance.

Purpose of the Study:

  • To investigate the mechanism by which Olaparib re-sensitizes leukemia cells to ADR.
  • To evaluate the efficacy of combining Olaparib with ADR in chemotherapy-resistant leukemia models.

Main Methods:

  • Annexin V-propidium iodide staining to assess apoptosis and cell cycle.
  • Alkaline comet assay to detect DNA damage.
  • Western blot analysis to examine protein expression related to DNA damage response and cell cycle.
  • Testing on K562/ADR cells and patient-derived leukemia cells.

Main Results:

  • Combination of ADR and Olaparib significantly increased apoptosis and induced G2/M cell cycle arrest in ADR-resistant leukemia cells.
  • The combined treatment markedly upregulated DNA damage response markers (e.g., γ-H2AX, cleaved PARP, cleaved caspase 3) and downregulated cyclin B1.
  • Synergistic cytotoxicity was observed in both cell lines and primary patient samples.

Conclusions:

  • Olaparib re-sensitizes leukemia cells to ADR by enhancing DNA damage and apoptosis.
  • The combination of Olaparib and ADR presents a potential therapeutic strategy for Adriamycin-resistant leukemia.
  • Clinical trials investigating Olaparib-based combination therapies for resistant leukemia are warranted.
Keywords:
Olaparibdrug resistanceleukemiaapoptosisAdriamycin

More Related Videos

Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors04:36

Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors

Published on: October 17, 2025

960
Laser Microirradiation to Study In Vivo Cellular Responses to Simple and Complex DNA Damage10:44

Laser Microirradiation to Study In Vivo Cellular Responses to Simple and Complex DNA Damage

Published on: January 31, 2018

10.8K

Related Concept Videos

DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.2K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.1K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.0K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
14.5K
Overview of DNA Repair02:25

Overview of DNA Repair

In order to be passed through generations, genomic DNA must be undamaged and error-free. However, every day, DNA in a cell undergoes several thousand to a million damaging events by natural causes and external factors. Ionizing radiation such as UV rays, free radicals produced during cellular respiration, and hydrolytic damage from metabolic reactions can alter the structure of DNA. Damages caused include single-base alteration, base dimerization, chain breaks, and cross-linkage.
Chemically...
33.7K
Resistivity01:22

Resistivity

When a voltage is applied to a conductor, an electrical field is generated, and charges in the conductor feel the force due to the electrical field. The current density that results depends on the electrical field and the properties of the material. In some materials, including metals at a given temperature, the current density is approximately proportional to the electrical field. In these cases, the current density can be modeled as:
4.6K